Prior authorization is overused, and existing processes present significant administrative and clinical concerns. That is why the AMA is fixing prior authorization by challenging insurance companies ...

The New England Journal of Medicine's editor in chief, Eric Rubin, received a letter from the interim U.S. attorney for the District of Columbia, Edward R. Martin Jr. in recent days in which the ...

UCSF is launching a remote patient monitoring program aimed at identifying arrhythmias in expectant mothers and improving ...

U.S. Bankruptcy Court Judge Stacey Jernigan approved Prospect Medical Holdings' move to shutter Crozer-Chester Medical Center ...

Novavax's closely watched COVID-19 vaccine is on track for full approval after additional discussions with the Food and Drug Administration, the company said Wednesday. The news sent company shares ...

Uncertainty about the future of Tallahassee Memorial Hospital brought a large crowd to Tuesday's meeting of the Network of Entrepreneurs and Business Advocates at the Capital City Country Club. They ...

Researchers have estimated approximately 8% of Americas have ever experienced long COVID, or lasting symptoms, following an acute COVID-19 infection. Now two recent international studies suggest that ...

In July 2022, "An Arm and a Leg" listener Meagan experienced a bout of vertigo that landed her in the emergency room. For more than two years after, Meagan endured what felt like a never-ending series ...

The measles outbreak in western Texas has now reached 624 cases, with 27 new infections confirmed over the last five days. Nearly all of the cases are among unvaccinated individuals or among those ...

The cuts have demoralized caseworkers, whose jobs demand a grasp of complex and arcane health insurance rules.

Nurses at University Medical Center in New Orleans are gearing up for their third strike on May 1 as contract talks with LCMC Health remain unresolved, NOLA.com reported.

A recent Executive Order takes aim at drug pricing, with significant implications for the 340B Drug Pricing Program.